Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.

McGarry A, McDermott MP, Kieburtz K, Alan Fung WL, McCusker E, Peng J, de Blieck EA, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators.

Neurology. 2019 Mar 8. pii: 10.1212/WNL.0000000000007244. doi: 10.1212/WNL.0000000000007244. [Epub ahead of print]

PMID:
30850442
2.

Suicidal ideation and suicidal behavior according to the C-SSRS in a European cohort of Huntington's disease gene expansion carriers.

van Duijn E, Vrijmoeth EM, Giltay EJ, Bernhard Landwehrmeyer G; REGISTRY investigators of the European Huntington's Disease Network.

J Affect Disord. 2018 Mar 1;228:194-204. doi: 10.1016/j.jad.2017.11.074. Epub 2017 Nov 15.

PMID:
29253686
3.

The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression.

Bingham KS, Rothschild AJ, Mulsant BH, Whyte EM, Meyers BS, Banerjee S, Szanto K, Flint AJ; STOP-PD Study Group.

J Clin Psychiatry. 2017 Sep/Oct;78(8):1149-1154. doi: 10.4088/JCP.16m10881.

PMID:
28445632
4.

Suicidal ideation in a European Huntington's disease population.

Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ; REGISTRY investigators of the European Huntington's Disease Network.

J Affect Disord. 2013 Oct;151(1):248-58. doi: 10.1016/j.jad.2013.06.001. Epub 2013 Jul 20.

5.

Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.

Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, Belanger E, James A, George S, Weber H, Graham DL, Schweitzer R, Ladd TB, Learman R, Niculescu EM, Vanipenta NP, Khan FN, Mullen J, Shankar G, Cook S, Humbert C, Ballew A, Yard M, Gelbart T, Shekhar A, Schork NJ, Kurian SM, Sandusky GE, Salomon DR.

Mol Psychiatry. 2015 Nov;20(11):1266-85. doi: 10.1038/mp.2015.112. Epub 2015 Aug 18.

6.

Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study.

Dorsey ER, Brocht AF, Nichols PE, Darwin KC, Anderson KE, Beck CA, Singh S, Biglan KM, Shoulson I.

J Huntingtons Dis. 2013;2(4):509-15. doi: 10.3233/JHD-130071.

PMID:
25062735
7.
8.

Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.

Carpenter DJ, Fong R, Kraus JE, Davies JT, Moore C, Thase ME.

J Clin Psychiatry. 2011 Nov;72(11):1503-14. doi: 10.4088/JCP.08m04927blu. Epub 2011 Feb 22.

PMID:
21367354
9.

Suicidal ideation and behavior in Huntington's disease: Systematic review and recommendations.

Kachian ZR, Cohen-Zimerman S, Bega D, Gordon B, Grafman J.

J Affect Disord. 2019 Mar 5;250:319-329. doi: 10.1016/j.jad.2019.03.043. [Epub ahead of print] Review.

PMID:
30875675
10.

Risk Factors for Suicidal Ideation in People at Risk for Huntington's Disease.

Anderson KE, Eberly S, Groves M, Kayson E, Marder K, Young AB, Shoulson I; PHAROS Investigators.

J Huntingtons Dis. 2016 Dec 15;5(4):389-394.

PMID:
27983561
11.

A Novel Brief Therapy for Patients Who Attempt Suicide: A 24-months Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP).

Gysin-Maillart A, Schwab S, Soravia L, Megert M, Michel K.

PLoS Med. 2016 Mar 1;13(3):e1001968. doi: 10.1371/journal.pmed.1001968. eCollection 2016 Mar.

12.

Understanding the relationship between suicidality, current depressed mood, personality, and cognitive factors.

Cameron S, Brown VJ, Dritschel B, Power K, Cook M.

Psychol Psychother. 2017 Dec;90(4):530-549. doi: 10.1111/papt.12123. Epub 2017 Mar 11.

PMID:
28296207
13.

Suicidality in Huntington's disease.

Hubers AA, Reedeker N, Giltay EJ, Roos RA, van Duijn E, van der Mast RC.

J Affect Disord. 2012 Feb;136(3):550-7. doi: 10.1016/j.jad.2011.10.031. Epub 2011 Nov 25.

PMID:
22119091
14.

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.

JAMA. 2007 Apr 18;297(15):1683-96.

PMID:
17440145
15.

Associations between health-related self-efficacy and suicidality.

Isaac V, Wu CY, McLachlan CS, Lee MB.

BMC Psychiatry. 2018 May 10;18(1):126. doi: 10.1186/s12888-018-1705-z.

17.

Suicidal ideation and suicide attempts in recent-onset schizophrenia.

Young AS, Nuechterlein KH, Mintz J, Ventura J, Gitlin M, Liberman RP.

Schizophr Bull. 1998;24(4):629-34.

PMID:
9853794
18.

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.

Beasley CM Jr, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN.

BMJ. 1991 Sep 21;303(6804):685-92. Erratum in: BMJ 1991 Oct 19;303(6808):968.

19.
20.

A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report.

Reilly-Harrington NA, Shelton RC, Kamali M, Rabideau DJ, Shesler LW, Trivedi MH, McElroy SL, Sylvia LG, Bowden CL, Ketter TA, Calabrese JR, Thase ME, Bobo WV, Deckersbach T, Tohen M, McInnis MG, Kocsis JH, Gold AK, Singh V, Finkelstein DM, Kinrys G, Nierenberg AA.

J Affect Disord. 2016 Mar 1;192:212-8. doi: 10.1016/j.jad.2015.12.036. Epub 2015 Dec 30.

PMID:
26748736

Supplemental Content

Support Center